Management of reproductive needs in cancer patients: Clinical perspectives

Expert Review of Anticancer Therapy

Volumn 8, Issue 10, 2008, Pages 1589-1595

  Mitwally, Mohamed F ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cancer survivor; Chemotherapy; Contraception; Fertility preservation; Radiotherapy; Reproduction

Indexed keywords

ALKYLATING AGENT; ALPHA TOCOPHEROL; AROMATASE INHIBITOR; CONTRACEPTIVE AGENT; GABAPENTIN; GONADORELIN DERIVATIVE; GONADOTROPIN DERIVATIVE; GROWTH HORMONE; PAROXETINE; SEX HORMONE; TESTOSTERONE; VENLAFAXINE;

ALTERNATIVE MEDICINE; ANDROLOGY; ARTICLE; BREAST CANCER; BREAST FEEDING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVOR; CANCER THERAPY; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; CONSULTATION; CONTRACEPTION; DISEASE SEVERITY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MECHANISM; EARLY MENOPAUSE; EMERGENCY CARE; FAMILIAL CANCER; FEMALE; FEMALE INFERTILITY; FERTILITY; FOLLOW UP; GONAD DYSFUNCTION; HEALTH CARE NEED; HODGKIN DISEASE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LONG TERM CARE; MENOPAUSAL SYNDROME; MONOTHERAPY; NEOPLASM; OVULATION INDUCTION; PATIENT EDUCATION; PREGNANCY OUTCOME; PREMATURE OVARIAN FAILURE; PRENATAL DIAGNOSIS; PUBERTY DISORDERS; RADIATION EXPOSURE; REPRODUCTIVE HEALTH; RISK FACTOR; TREATMENT CONTRAINDICATION;

CONTRACEPTION; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HORMONE REPLACEMENT THERAPY; HUMANS; NEOPLASMS; OVARY; REPRODUCTION; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 55249111339     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.8.10.1589     Document Type: Article

References (53)

1. Mitwally MF. Effect of cancer and cancer treatment on human reproduction. Expert Rev. Anticancer Ther. 7, 811-822 (2007).
2. Mitwally MFM. Fertility preservation and minimizing reproductive damage in cancer survivors. Expert Rev. Anticancer Ther. 7, 989-1001 (2007).
3. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J. Clin. 57, 43-66 (2007).
4. Carver JR, Shapiro CL, Ng A et al. American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects. J. Clin. Oncol. 25, 3991-4008 (2007).
5. Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA, McTavish AR. Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst. Rev. (1), CD004379 (2007).
6. Bath LE, Tydeman G, Critchley HOD, Anderson RA, Baird DT, Wallace WHB. Spontaneous concepcion in a young woman who had ovarian cortical tissue cryopreserved before chemotherapy and radiotherapy for a Ewing's sarcoma of the pelvis. Hum. Reprod. 19(11), 2569-2572 (2004).
7. Wallace WH, Anderson RA, Irvine DI. Fertility preservation for young people with cancer: who is at risk and what can be offered? Lancet Oncol. 6, 209-218 (2005).
8. Larsen EC, Müller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation and chemotherapy-treated childhood cancer. J. Clin. Endocrinol. Metab. 88, 5307-5314 (2003).
9. Sklar CA, Mertens AC, Mitby P et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J. Natl Cancer Inst. 98(13), 890-896 (2006).
10. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod. 7, 1342-1346 (1992).
11. Santoro N. Mechanisms of premature ovarian failure. Ann. Endocrinol. (Paris) 64(2), 87-92 (2003).
12. Hargis JB, Nakajima ST. Resumption of menses with initiation of letrozole after five years of amenorrhea on tamoxifen: caution needed when using tamoxifen followed by aromatase inhibitors. Cancer Invest. 24(2), 174-177 (2006).
13. Mitwally MFM, Casper RF. Potential of aromatase inhibitors for ovulation and superovulation induction in infertile women. Drugs 66(17), 2149-2160 (2006).
14. Mitwally MFM, Casper RF. Letrozole for ovulation induction. Expert Rev. Obstet. Gynecol. 1(1), 15-27 (2006).
15. Casper RF, Mitwally MFM. Aromatase inhibitors for ovulation induction. J. Clin. Endocrinol. Metab. 91(3), 760-771 (2006).
16. Mitwally MFM, Casper FR. Using aromatase inhibitors to induce ovulation in breast Ca survivors. Contemp. Ob. Gyn. 49(1), 73-83 (2004).
17. Mitwally MFM, Casper RF. Preventing breast cancer with aromatase inhibition. Contemp. Ob. Gyn. 48(12), 68-80 (2003).
18. Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J. Clin. Endocrinol. Metab. 92(6), 2197-2200 (2007).
19. Azim A, Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil. Steril. 88(3), 657-664 (2007).
20. Oktay K, Hourvitz A, Sabin G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J. Clin. Endocrinol. Metab. 91, 3885-3890 (2006).
21. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J. Clin. Oncol. 23, 4347-4353 (2005).
22. Oktay K, Buyuk E, Davis O, Yermakova I, Veek L, Rozenwaks Z. Fertility preservation in breast cancer patients: in vitro fertilization and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum. Reprod. 18, 90-95 (2003).
23. Mitwally MFM, Bilijan M, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for induction of ovulation. Am. J. Obstet. Gynecol. 192(2), 381-386 (2005).
24. Tulandi T, Martin J, Al-Fadhli R et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil. Steril. 85(6), 1761-1765 (2006).
25. Edgar AB, Wallace WH. Pregnancy in women who had cancer in childhood. Eur. J. Cancer 43(13), 1890-1894 (2007).
26. Connell S, Patterson C, Newman B. A qualitative analysis of reproductive issues raised by young Australian women with breast cancer. Health Care Women Int. 27, 94-110 (2006).
27. Petrek JA. Breast cancer during pregnancy. Cancer 74, 518-527 (1994).
28. Neifert M. Breastfeeding after breast surgical procedure or breast cancer. NAACOGS Clin. Issu. Perinat. Womens Health Nurs. 3(4), 673-682 (1992).
29. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet 360, 187-195 (2002).
30. Higgins S, Haffty BG. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer. Cancer 73(8), 2175-2180 (1994).
31. Geraedts JP, Harper J, Braude P et al. Preimplantation genetic diagnosis (PGD), a collaborative activity of clinical genetic departments and IVF centres. Prenat. Diagn. 21, 1086-1092 (2001).
32. Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasia. J. Natl. Cancer Inst. Monographs 34, 87-90 (2005).
33. Garber JE, Offit K. Hereditary cancer predisposition syndromes. J. Clin. Oncol. 23(2), 276-292 (2005).
34. Robertson JA. Extending preimplantation genetic diagnosis: the ethical debate. Hum. Reprod. 18(3), 465-471 (2003).
35. Temizkan M, Ouwendijk JT, Middelkoop MP, Blankenstein M, ten Kate FJ, Tytgar GN. A young female with a cholangiocarcinorna in the past: is pregnancy allowed? Acta Gastroenterol. Latinoam. 26(1), 31-34 (1996).
36. Critchley HO, Wallace WH. Do survivors of childhood cancer have increased incidence of premature menopause? Nat. Clin. Pract. Oncol. 4(2), 84-85 (2007).
37. Somali M, Mpatakoias V, Avramides A et al. Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases. Gynecol. Endocrinol. 21(1), 18-26 (2005).
38. Greenfield DM. Walters SJ, Coleman RE et al. Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J. Clin. Endocrinol. Metab. 92(9), 3476-3482 (2007).
39. Goodwin M, Loprinzi C, Bordeleau L et al. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clin. Ther. 29(2), 230-241 (2007).
40. Morgentaler A. Testosterone therapy for men at risk for or with history of prostate cancer. Curr. Treat. Options Oncol. 7(5), 363-369 (2006).
41. Mulder JE. Benefits and risks of hormone replacement therapy in young adult cancer survivors with gonadal failure. Med. Pediatr. Oncol. 33(1), 46-52 (1999).
42. Müller J. Disturbance of pubertal development after cancer treatment. Best Pract. Res. Clin. Endocrinol. Metab. 16(1), 91-103 (2002).
43. Adan L, Souberbielle JC, Blanche S. Adult height after cranial irradiation with 24 Gy: factors and markers of height loss. Acta Paediatrica 85, 1096-1101 (1996).
44. Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr. Relat. Cancer 11(4), 589-602 (2004).
45. Darzy KH, Pezzoli SS, Thorner MO, Shalet SM. The dynamics of growth hormone (GH) secretion in adult cancer survivors with severe GH deficiency acquired after brain irradiation in childhood for nonpituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increased secretory disorderliness. J. Clin. Endocrinol. Metab. 90(5), 2794-2803 (2005).
46. Didcock V, Davies HA, Didi M. Pubertal growth in young adult survivors of childhood leukemia. J. Clin. Oncol. 13, 2503-2507 (1995).
47. Groot-Loonen JJ, van Setten P, Otten BJ. Shortened and diminished pubertal growth in boys and girls treated for acute lymphoblastic leukaemia. Acta Paediatrica 85, 1091-1095 (1996).
48. Hokken-Koelega CS, van Doorn WD, Hählen K. Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty; a comparative study. Pediatr. Res. 33, 577-582 (1993).
49. Melin E, Adan L, Leverger G. Growth hormone secretion, puberty and adult height after cranial irradiation with 18 Gy for leukaemia. Eur. J. Pediatr. 157, 703-707 (1998).
50. Moëll C, Marky I, Hovi L. Cerebral irradiation causes blunted pubertal growth in girls treated for acute leukemia. Med. Pediatr. Oncol. 22, 375-379 (1994).
51. Moell C, Garwicz S, Westgren U, Wiebe T. Disturbed pubertal growth in girls treated for acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 4, 1-5 (1987).
52. Mohnike K, Dorffel W, Timme J. Final height and puberty in 40 patients after antileukaemic treatment during childhood. Eur. J. Pediatr. 156, 272-276 (1997).
53. Maneschi F, Fugardi MG, Corsello G, LoCurto M. Pubertal maturation in girls treated for childhood acute leukaemia. Eur. J. Pediatr. 150, 630-633 (1991).